MolecuLight Inc., a global leader in fluorescence imaging technology for real-time detection of harmful bacteria and digital wound measurement, is set to make a significant impact at the Symposium on Advanced Wound Care (SAWC) Fall 2024. This prestigious interdisciplinary event, aimed at enhancing patient outcomes, takes place from October 2 to 5, 2024, in Las Vegas, Nevada. The symposium is one of the largest gatherings of wound care professionals globally.
At SAWC Fall 2024, MolecuLight will present ten clinical posters highlighting the advancements and applications of its innovative imaging technology. The MolecuLight and DX™ imaging devices will also be available for demonstration at Booth #431 in the Exhibition Hall.
The clinical posters represent a diverse range of applications, showcasing the latest features of MolecuLight’s devices. Key topics include optimised wound bed preparation prior to skin grafting, automatic digital wound depth measurement to enhance workflow, and thermal imaging techniques designed to detect and treat pressure injuries more effectively. Additionally, the research explores the association between fluorescence signals and healing in diabetic ulcers, underscoring the company’s commitment to advancing wound care.
Anil Amlani, CEO of MolecuLight, expressed enthusiasm about the company’s strong presence at SAWC Fall 2024. “We are thrilled to see such a robust representation of MolecuLight research, demonstrating the growing adoption and support for our technology,” he said. “The ten clinical posters being presented highlight the expanding body of evidence that supports the implementation of our technology as part of the standard of care for wound infection management, which has proven to enhance patient outcomes.”
Amlani further emphasised the unique capabilities of MolecuLight’s technology, which integrates multiple functions to provide clinicians with a comprehensive overview of wound evolution. The devices document interventions and findings, enriching patient encounters with precise, point-of-care information about bacterial burden and wound size.
The clinical posters presented at SAWC Fall 2024 include:
- Poster CR-001: “Imaging Beyond the Wound Bed: Leveraging Fluorescence Imaging of Non-Biologicals to Enhance Bacterial-Infection Management,” presented by Dr. Charles Andersen.
- Poster CR-002: “The New Age of Wound Care: Leveraging the Synergy of Multi-modal Fluorescence and Thermal Imaging,” presented by Dr. Charles Andersen.
- Poster CR-020: “Validation of a Digital Automatic-Depth Measurement Feature within a Multi-Modal Wound Imaging Device,” presented by Dr. Laura Jones.
- Poster CR-029: “Bacterial Fluorescence Imaging Improves Chronic Wound Biofilm Detection Over Standard Clinical Assessment and Blotting,” presented by Dr. Laura Jones.
- Poster CR-063: “Bacterial Fluorescence in the Application of Cellular Tissue Products,” presented by Dr. Alisha Oropallo.
- Poster CR-064: “Co-localisation of High Bacterial Load with Regions of Pain in Venous Leg Ulcers: Fluorescence Imaging Informs Interventions and Validates Patient Self-Reported Pain,” presented by Dr. Alisha Oropallo.
- Poster CS-012: “Advancing Pyoderma Gangrenosum Wound Care Through Fluorescence-Guided Debridement,” presented by Dr. Charles Andersen.
- Poster CS-115: “The Interface of Cutting-Edge Technology in Mission Sustained Injuries of U.S. Special Operations,” presented by Dr. Charles Andersen.
- Poster CS-151: “The Association of Bacterial Autofluorescence Signals with Healing Outcomes in Diabetic Foot Ulcers,” presented by Dr. Stephanie Woelfel.
- Poster CS-157: “Update on Pressure Ulcer Diagnosis and Management: Leveraging Fluorescence and Thermal Imaging,” presented by Dr. Charles Andersen.
With a commitment to improving patient outcomes through innovative technology, MolecuLight aims to further its role in transforming wound care at SAWC Fall 2024.
